Huge Opportunities for Indian Generics Drug Sector Ramping up in the US

Backed by factors like patent expiries of blockbuster drugs and strong demand, the Indian generics drug market will grow at a CAGR of 17% between FY 2011 and FY 2013.

NOIDA, India (prHWY.com) August 1, 2011 - According to our latest report, "Booming Generics Drug Market in India", the Indian generics drug market has been growing at a rapid pace over the past few years. Despite the recession, the market continued to perform well and reached an estimated mark of US$ 17 Billion in FY 2010. Factors including patent expiries, increasing awareness & access, and private investment are the prominent growth drivers that will lead Indian generics market to grow at a CAGR of around 17% between FY 2011 and FY 2013.

We have found that US is the key destination for expanding Indian drug manufacturers, as a large number of drugs are scheduled to go off patent. In 2012, drugs worth US$ 35.4 Billion are likely to lose their patents in the US. This creates a huge opportunity for Indian companies, who already have enjoyed 10.5% share in the US generics market. In this regard, our report analyzes the opportunity for Indian drug manufacturers in key regions of the world.

The report, "Booming Generics Drug Market in India", addresses all the pertinent issues related to generics drug market in India and covers information on the market development. The report also investigates the current trends and discusses their impact on the market performance. Regulatory environment has also been analyzed so that client may acquaint themselves with the government role in market development.

The report is an outcome of prudent research and in-depth analysis of several segments, such as API and formulation drugs of Indian generic and pharmaceutical market. The forecast is done after comprehending the current market scenario, past trends and ongoing developments in the industry. A brief description, strength-weakness analysis and recent developments of key market players have also been included in order to analyze private sector participation.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM256.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: india pharma

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code